Beyond the signaling effect role of amyloid-ß42 on the processing of APP, and its clinical implications (original) (raw)
Related papers
Experimental Neurology, 2010
Signaling effect of amyloid-beta(42) on the processing of AbetaPP
Experimental neurology, 2010
Amyloid beta as a regulator of lipid homeostasis
Trends in Molecular Medicine, 2007
Targeting APP metabolism for the treatment of Alzheimer's disease
Drug Development Research, 2002
Signaling effect of amyloid-β42 on the processing of AβPP
Experimental Neurology, 2010
Functional activity of the novel Alzheimer's amyloid �-peptide interacting domain (A�ID) in the APP
Fuel and Energy Abstracts, 2011
Endogenous murine Aβ increases amyloid deposition in APP23 but not in APPPS1 transgenic mice
Neurobiology of Aging, 2015
Novel therapeutic strategies provide the real test for the amyloid hypothesis of Alzheimer's disease
Trends in Pharmacological Sciences, 2002
Restored degradation of the Alzheimer’s amyloid-β peptide by targeting amyloid formation
Journal of Neurochemistry, 2009
Acta Neurologica Scandinavica, 2000
Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer’s disease?
Journal of Neurochemistry, 2012
Alzheimer’s disease pathogenesis and therapeutic interventions
Journal of Clinical Neuroscience, 2004
Alzheimer's disease: molecular concepts and therapeutic targets
Naturwissenschaften, 2001
β-Site APP-cleaving enzyme 1 trafficking and Alzheimer’s disease pathogenesis
Journal of Neurochemistry, 2012
Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease
Current Pharmaceutical Design, 2008
Alzheimer's Disease: Molecular Mechanisms
Amyloid β and APP as biomarkers for Alzheimer’s disease
Experimental Gerontology, 2010
Can novel therapeutics halt the amyloid cascade?
2010
Key Enzymes and Proteins in Amyloid-Beta Production and Clearance
Alzheimer's Disease Pathogenesis-Core Concepts, Shifting Paradigms and Therapeutic Targets, 2011
A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
Nature, 2012
J Biol Chem, 2002
Neurodegenerative Diseases, 2007
Pharmacological targeting of the β-amyloid precursor protein intracellular domain
Scientific Reports, 2014
The role of Abeta peptides in Alzheimer's disease
Protein and peptide letters, 2005
ChemMedChem, 2015
Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer’s Disease
Current Alzheimer Research, 2015
International Journal of Molecular Sciences
BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild-type mice
Journal of Neurochemistry, 2006
Alzheimer disease -amyloid activity mimics cholesterol oxidase
Journal of Clinical Investigation, 2006